TY  - BOOK
AU  - Van Nostrand, Douglas
AU  - Wartofsky, Leonard
AU  - Ylli, Dorina
TI  - Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review]
SN  - 0889-8529
PY  - 2019///
KW  - *Iodine Radioisotopes/tu [Therapeutic Use]
KW  - *Thyroid Neoplasms/rt [Radiotherapy]
KW  - Humans
KW  - Iodine Radioisotopes/ad [Administration & Dosage]
KW  - MedStar Health Research Institute
KW  - MedStar Washington Hospital Center
KW  - Medicine/Endocrinology
KW  - Medicine/Nuclear Medicine
KW  - Journal Article
KW  - Review
N1  - Available online from MWHC library: 1996 - present
N2  - Copyright (c) 2018 Elsevier Inc. All rights reserved; This article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients with differentiated thyroid cancer. Topics reviewed include definitions; staging; the 2 principal methods for selection of 131-I dosage; the indications for ablation, adjuvant treatment, and treatment; the recommendations for the use of 131-I contained in the guidelines of the American Thyroid Association and the Society of Nuclear Medicine and Molecular Imaging; the dosage recommendations and selection of dosage approach for 131-I by these organizations; the use of recombinant human thyrotropin for radioiodine ablation, adjuvant therapy, or treatment; and the MedStar Washington Hospital Center approach
UR  - https://dx.doi.org/10.1016/j.ecl.2018.11.005
ER  -